| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |